Project Grant HT94252410714
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$494K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $131,685 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETED AUDITORY PLASTICITY TRAINING TO IMPROVE CENTRAL HEARING IN MILD TBI", will support research to develop innovative approaches for improving central hearing in individuals with mild traumatic brain injury. The grant has a performance...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $6,133,100 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 4-year research project to develop and validate personalized treatment models for persistent headaches attributable to mild traumatic brain injury in U.S. military service members and veterans. The research includes specifying and validating patient-centered models...
The University of Texas Health Science Center of San Antonio (UTHSCSA) received a $978,159 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into purinergic receptor antagonist therapeutics for treating metastatic renal cancer from July 1, 2023 through June 30, 2026. As the prime awardee, UTHSCSA will conduct research to develop medical solutions for cancer on the battlefield and...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
This federal Project Grant award from the Defense Health Agency (DHA), under the Military Medical Research and Development program (CFDA 12.420), provides $433,126.00 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to explore the role of PACAP38 in post-traumatic headache. The research aims to advance understanding and treatment of this condition, which is particularly relevant to military personnel. The award period runs from January 1, 2025 to December 31, 2027....
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...